ATAD1 and malaria: The C-terminal of the P. falciparum MSP1 protein, PfMSP119, has already shown to be related to the acquisition of clinical immunity, which is probably cumulative, with the expansion and refinement of a repertoire of antibodies, protecting the individual from severe malaria, which is a rare event in the Amazon region [38].